CIK 0001980845 · <br>Emerging growth company
enGene Therapeutics Inc.
Sign in to watch- Ticker
- ENGN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Oct 31
- Incorporated
- Canada (Federal Level)
- Entity type
- operating
- Phone
- (514) 332-4888
- Business address
- 4868 RUE LEVY, SUITE 220, SAINT-LAURENT, Quebec, Canada
- Former names
- enGene Holdings Inc.
Securities
- ENGN Common Stock Nasdaq
- ENGNW Warrants Nasdaq
- Open-market buys, last 90 days
- $10,051
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$10,051. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-04-22 | FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC 10% owner | Sale | −47,854 | $15.00 | $718K | 3,036,153 |
| 2024-04-19 | FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC 10% owner | Sale | −100 | $15.00 | $2K | 3,084,007 |
| 2024-04-18 | FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC 10% owner | Sale | −4,575 | $15.01 | $69K | 3,084,107 |
Page 1 of 1 · 3 trades